Posts Tagged ‘pharmaceuticals’

Hood subpoenas Google’s records over online drug sales

JACKSON — Attorney General Jim Hood says he still considers Google’s responses to allegations that it’s not doing enough to prevent illegal online sales of drugs without prescriptions and says he’s sending out subpoenas for company documents to further his investigation. Hood urged fellow attorneys general from other states to do the same at a […] [...]

Physician pleads guilty to writing fake prescriptions; to repay $1.6M

NATCHEZ — A Mississippi physician who wrote fake prescriptions that helped defraud Medicare of more than $5 million lost her medical license and has been ordered in Baton Rouge, La., federal court to repay the insurer $1.6 million. Dr. Jo A. Francis, of Natchez, pleaded guilty to two counts of conspiracy to commit health care […] [...]

Associate director at VA hospital arrested for prescription drug fraud

JACKSON — An associate director at a Veterans Affairs hospital in Mississippi has been arrested and charged with prescription fraud as part of an ongoing investigation, authorities said Thursday. Dorothy White-Taylor, 59, the associate director of patient care services at the G.V. (Sonny) Montgomery VA Medical Center in Jackson, was arrested Tuesday and released on […] [...]

Pharmaceutical company settles civil allegations for $2.8M

MADISON — A Mississippi-based pharmaceutical company has agreed to pay $2.8 million to resolve civil allegations that the manufacturer falsely marketed skin products to receive government funding. U.S. Attorney John M. Bales said yesterday Cypress Pharmaceutical Inc., a subsidiary and CEO Max Draughn will pay $1.6 million to the military’s TRICARE program and $1.2 million […] [...]

Hood preparing fight to keep $17M from settlement

JACKSON — Attorney General Jim Hood has asked the federal government to give him until Jan. 30 to file documents supporting Mississippi’s effort to keep $17 million from a settlement with pharmaceutical companies accused of inflating wholesale prices. Alper Ozinal, spokesman for the federal Centers for Medicare and Medicaid Services, tells the Clarion-Ledger the agency […] [...]

Ex-surgeon gets jail time for writing illegal prescriptions

GULFPORT — A former Gulf Coast surgeon has been sentenced to more than 11 years in prison for writing and selling illegal prescriptions. In addition to the 135-month prison term, 43-year-old Je Song also was fined $10,000 by U.S. District Judge Sul Ozerden in Gulfport. The Sun Herald said a co-defendant — 41-year-old Oliver “Butch” […] [...]

Pharmaceutical companies pay state in fraud case

JACKSON — The Mississippi Attorney General’s Office says it has recovered $6 million from three pharmaceutical companies that misreported the price of prescription drugs for Medicaid patients. In a statement, Attorney General Jim Hood says agreements were reached with Par Pharmaceutical Inc. and Alpharma USPD Inc. and Purepac Pharmaceutical Co., now known as Actavis MidAtlantic, […] [...]

Ex-doctor expected to plead guilty to drug-dealing

SAUCIER — A former Mississippi doctor and another man are scheduled to plead guilty today to selling prescriptions for pain pills and anxiety drugs to people without a legitimate medical exam. Authorities said Je Song, a former Stone County doctor, wrote prescriptions that ended up in the hands of people he never examined, and in […] [...]

Pharmacy’s growth makes Inc. 5000 ranking

JACKSON — Transcript Pharmacy has landed on the Inc. 5000 list of the fastest-growing privately owned businesses in America for the fourth year in a row. It ranked 116 in the health industry. “We are blessed to be trusted by so many healthcare professionals and so many patients who, month after month, give us the […] [...]

Hawthorn Pharmaceuticals cuts global deal with CoPlex

by Published: September 13,2011

Tags: healthcare, licenses, medicines, pharmaceuticals, sales

MADISON — Hawthorn Pharmaceuticals Inc. has struck an exclusive global licensing deal with CoPlex Therapeutics on hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer’s and other neurodegenerative diseases. Under the terms of the agreement, Hawthorn will receive an exclusive worldwide license to develop and commercialize hawAD14 and will be responsible for […] [...]

Next Page »

Recent Posts

Polls

How ready is your business for health care reform?

View Results

The MBJ poll should not be considered a scientific one. Results reflect only the opinion of those who participate.

Loading ... Loading ...

Recent Comments